Herminia López-G de la Serrana

Learn More
Serum and urine selenium levels were determined in patients with diabetes by hydride generation atomic absorption spectrometry. Mean serum selenium concentrations measured in patients with diabetes mellitus (64.9 +/- 22.8 micrograms/l) were significantly lower than those determined in the control group (74.9 +/- 27.3 micrograms/l) (P < 0.05). Mean serum(More)
A single cross-sectional study for serum copper and zinc levels was evaluated in 20 patients with cancer (respiratory, digestive, haematological, gynaecological) and 21 patients with cardiopathy (acute myocardial infarction and ischemic cardiomyopathy). A control group of 84 healthy subjects was selected. The mean serum zinc levels in patients with(More)
OBJECTIVES We determined zinc (Zn) dialyzability as an indicator of Zn bioavailability in the in vitro gastrointestinal digests of 108 duplicate meals. The interaction exerted by levels of 51 nutrients and energy on total and dialyzable Zn fractions and on Zn dialyzability was also assessed. METHODS Total and dialyzable Zn levels were measured by flame(More)
Copper levels in serum samples of 84 healthy subjects living in southeastern Spain were determined using the flame atomic absorption spectrometry technique. Mineralization of samples was carried out with an HNO3/HClO4 (4:1) mixture in a thermostated mineralization block. The accuracy of the method was tested by using a standard reference material. A mean(More)
The serum zinc and copper levels, as well as Zn/Cu ratios, were determined in 30 patients (18 with diabetes and 12 with hepatopathies) and compared to healthy-age matched controls by atomic absorption spectrometry. Serum Zn (0.946 +/- 0.302 mg/l) and Cu (0.952 +/- 0.355 mg/l) concentrations were not significantly different in patients with hepatopathies as(More)
  • 1